Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension

Atsuhiro Ichihara, Yuki Kaneshiro, Tomoko Takemitsu, Mariyo Sakoda, Fumiaki Suzuki, Tsutomu Nakagawa, Akira Nishiyama, Tadashi Inagami, Matsuhiko Hayashi

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric "handle region" I11PLLKK15P. We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin-angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.

Original languageEnglish
Pages (from-to)894-900
Number of pages7
JournalHypertension
Volume47
Issue number5
DOIs
Publication statusPublished - 2006 May

Fingerprint

Renin
Fibrosis
Hypertension
Renin-Angiotensin System
Peptides
Catalytic Domain
Arterial Pressure
Antibodies
Inbred SHR Rats
Proteolysis
Salts
Immunohistochemistry
Stroke
Staining and Labeling
Diet
Messenger RNA

Keywords

  • Angiotensin
  • Antibodies
  • Renin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Ichihara, A., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Suzuki, F., Nakagawa, T., ... Hayashi, M. (2006). Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension, 47(5), 894-900. https://doi.org/10.1161/01.HYP.0000215838.48170.0b

Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. / Ichihara, Atsuhiro; Kaneshiro, Yuki; Takemitsu, Tomoko; Sakoda, Mariyo; Suzuki, Fumiaki; Nakagawa, Tsutomu; Nishiyama, Akira; Inagami, Tadashi; Hayashi, Matsuhiko.

In: Hypertension, Vol. 47, No. 5, 05.2006, p. 894-900.

Research output: Contribution to journalArticle

Ichihara, A, Kaneshiro, Y, Takemitsu, T, Sakoda, M, Suzuki, F, Nakagawa, T, Nishiyama, A, Inagami, T & Hayashi, M 2006, 'Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension', Hypertension, vol. 47, no. 5, pp. 894-900. https://doi.org/10.1161/01.HYP.0000215838.48170.0b
Ichihara, Atsuhiro ; Kaneshiro, Yuki ; Takemitsu, Tomoko ; Sakoda, Mariyo ; Suzuki, Fumiaki ; Nakagawa, Tsutomu ; Nishiyama, Akira ; Inagami, Tadashi ; Hayashi, Matsuhiko. / Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. In: Hypertension. 2006 ; Vol. 47, No. 5. pp. 894-900.
@article{41e4128401d84853954738b75be3ad47,
title = "Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension",
abstract = "In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric {"}handle region{"} I11PLLKK15P. We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin-angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.",
keywords = "Angiotensin, Antibodies, Renin",
author = "Atsuhiro Ichihara and Yuki Kaneshiro and Tomoko Takemitsu and Mariyo Sakoda and Fumiaki Suzuki and Tsutomu Nakagawa and Akira Nishiyama and Tadashi Inagami and Matsuhiko Hayashi",
year = "2006",
month = "5",
doi = "10.1161/01.HYP.0000215838.48170.0b",
language = "English",
volume = "47",
pages = "894--900",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension

AU - Ichihara, Atsuhiro

AU - Kaneshiro, Yuki

AU - Takemitsu, Tomoko

AU - Sakoda, Mariyo

AU - Suzuki, Fumiaki

AU - Nakagawa, Tsutomu

AU - Nishiyama, Akira

AU - Inagami, Tadashi

AU - Hayashi, Matsuhiko

PY - 2006/5

Y1 - 2006/5

N2 - In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric "handle region" I11PLLKK15P. We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin-angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.

AB - In contrast to proteolytic activation of inactive prorenin by cleavage of the N-terminal 43 residue peptide, we found that prorenin is activated without proteolysis by binding of the prorenin receptor to the pentameric "handle region" I11PLLKK15P. We hypothesized that such activation occurs in hypertensive rats and causes cardiac renin-angiotensin system (RAS) activation and end-organ damage. To test this hypothesis, we devised methods of specifically inhibiting nonproteolytic activation by decapeptide spanning the pentameric handle region peptide as a decoy. In stroke-prone spontaneously hypertensive rats (SHRsp) fed a high-salt diet, arterial pressure started to rise significantly with a marked increase in the cardiac prorenin receptor mRNA level at 8 weeks of age, and cardiac fibrosis had developed by 12 weeks of age. By immunohistochemistry using antibodies to the active site of the renin molecule, we demonstrated increased proteolytic or nonproteolytic activation of prorenin in the heart but not in plasma of SHRsp. Continuous subcutaneous administration of the handle region peptide completely inhibited the increased staining by antibodies to the active site of the renin molecule, indicating the increased nonproteolytic but not proteolytic activation of prorenin in the heart of SHRsp. Administration of the handle region peptide also inactivated tissue RAS without affecting circulating RAS or arterial pressure and significantly attenuated the development and progression of cardiac fibrosis. These results clearly demonstrate the significant role of nonproteolytically activated tissue prorenin in tissue RAS activation leading to cardiac fibrosis and significant inhibition of the cardiac damage produced by chronic infusion of the handle region peptide.

KW - Angiotensin

KW - Antibodies

KW - Renin

UR - http://www.scopus.com/inward/record.url?scp=33646160993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646160993&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000215838.48170.0b

DO - 10.1161/01.HYP.0000215838.48170.0b

M3 - Article

C2 - 16585419

AN - SCOPUS:33646160993

VL - 47

SP - 894

EP - 900

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -